Clinical Trial Update: Biomarkers to Classify Young Patients With Acute Lymphoblastic Leukemia (ALL) and Remission Induction Therapy in Young Patients With B-Precursor ALL [NA]

View source ↗

Summary

This clinical trial update discusses biomarkers used to classify young patients with acute lymphoblastic leukemia and their remission-induction therapy for B-pr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Snippet

Sponsor: Children's Oncology Group | Conditions: Leukemia | NA | Status: COMPLETED